We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3898:HKEXZhuzhou CRRC Times Electric Co., Ltd. Class H Analysis

Data as of 2026-06-12 - not real-time

HK$39.56

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Zhuzhou CRRC Times Electric trades at a **PE of 11.4×**, far below the industry average of 30.6×, and offers a **dividend yield of 5.98%** with a comfortable **payout ratio of 48%**. The company generates solid margins (gross 33%, operating 15%) and holds a strong cash position (HK$8.1bn) against modest debt (HK$0.48bn), supporting dividend sustainability. However, the DCF‑derived fair value of **HK$17.2** is less than half the current market price of **HK$39.6**, indicating the stock is **overvalued** on a discounted cash‑flow basis.
Technical signals are mixed: the 20‑day SMA (40.83) sits just above the 50‑day SMA (38.90) while price hovers near the **support level of 38.5**, and the **MACD histogram is negative**, signaling short‑term bearish momentum. RSI at 48 suggests a neutral stance, but decreasing volume and a high 30‑day volatility of ~68% add caution. The low beta (~0.1) points to limited market‑wide risk, yet sector‑specific and regulatory exposures in China remain medium. Overall, the stock’s income appeal is strong, but price appreciation appears constrained in the near term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram
  • Decreasing volume trend
  • Price near immediate support at 38.5

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Attractive dividend yield and sustainable payout
  • Strong operating margins and low debt
  • Current market price exceeds DCF fair value

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable high dividend and cash flow generation
  • Growth opportunities in rail transit and new‑energy segments
  • Low beta and defensive industrial exposure

Key Metrics & Analysis

Financial Health

Revenue Growth12.50%
Profit Margin14.04%
P/E Ratio11.4
ROE9.42%
ROA4.06%
Debt/Equity1.04
P/B Ratio1.1
Op. Cash FlowHK$3.0B
Free Cash FlowHK$690.6M
Industry P/E30.6

Technical Analysis

TrendNeutral
RSI47.9
SupportHK$38.50
ResistanceHK$45.00
MA 20HK$40.83
MA 50HK$38.90
MA 200HK$39.93
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair ValueHK$17.23
Target PriceHK$44.72
Upside/Downside13.05%
GradeOvervalued
TypeBlend
Dividend Yield5.98%

Risk Assessment

Beta0.37
Volatility68.53%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.